| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 233 |
| 1 | ADALIMUMAB | 230 |
| 2 | INFLIXIMAB | 219 |
| 3 | LEFLUNOMIDE | 219 |
| 4 | METHOTREXATE | 219 |
| 5 | ETANERCEPT | 218 |
| 6 | SULFASALAZINE | 212 |
| 7 | RITUXIMAB | 211 |
| 8 | TOCILIZUMAB | 208 |
| 9 | ABATACEPT | 205 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FEBUXOSTAT TABLETS 40 MG | 116 | 0.0115 |
| 1 | DIMENHYDRINATE | 115 | 0.0109 |
| 2 | GOLD | 47 | 0.0082 |
| 3 | TETRACAINE HYDROCHLORIDE | 1 | 0.0081 |
| 4 | FEBUXOSTAT | 129 | 0.0077 |
| 5 | GOLIMUMAB | 82 | 0.0067 |
| 6 | COLCHICINE | 128 | 0.0049 |
| 7 | AMMONIUM CHLORIDE | 1 | 0.0042 |
| 8 | IBUPROFEN AND DIPHENHYDRAMINE CITRATE | 91 | 0.0039 |
| 9 | ADALIMUMAB-FKJP | 167 | 0.0036 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 236 |
| 1 | Antirheumatic Agent [EPC] | 219 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 219 |
| 3 | Aminosalicylate [EPC] | 212 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 211 |
| 5 | Interleukin-6 Receptor Antagonist [EPC] | 209 |
| 6 | Selective T Cell Costimulation Modulator [EPC] | 205 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 170 |
| 8 | Corticosteroid [EPC] | 160 |
| 9 | Vitamin B12 [EPC] | 146 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Alkaloid [EPC] | 128 | 0.0049 |
| 1 | Antirheumatic Agent [EPC] | 219 | 0.0021 |
| 2 | Aminosalicylate [EPC] | 212 | 0.0016 |
| 3 | Interleukin-6 Receptor Antagonist [EPC] | 209 | 0.0015 |
| 4 | Selective T Cell Costimulation Modulator [EPC] | 205 | 0.0015 |
| 5 | Interleukin-12 Antagonist [EPC] | 127 | 0.0012 |
| 6 | Calcineurin Inhibitor Immunosuppressant [EPC] | 107 | 0.0009 |
| 7 | Phosphodiesterase 4 Inhibitor [EPC] | 130 | 0.0008 |
| 8 | Xanthine Oxidase Inhibitor [EPC] | 129 | 0.0008 |
| 9 | CD20-directed Cytolytic Antibody [EPC] | 211 | 0.0006 |